Asosiy kontentga oʻtish
AkademIndex

Mahsulotlar

Ishlab chiquvchilar uchun

AkademBaseEkotizim uchun ochiq API
← Ishga qaytish

Ushbu ish iqtibos qilgan ishlar

172 ta ish

Ish: A systematic review of the protective effects of silymarin/silibinin against doxorubicin-induced cardiotoxicity

  1. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

    David Moher, Alessandro Liberati, Jennifer Tetzlaff +2

    Maqola200912 iqtibos
    ABI

  2. Synergic effects of nanoparticles-mediated hyperthermia in radiotherapy/chemotherapy of cancer

    Keywan Mortezaee, Asghar Narmani, Majid Salehi +4

    Sharh maqola20218 iqtibos
    ABI

  3. Abscopal effect in radioimmunotherapy

    Milad Ashrafizadeh, Bagher Farhood, Ahmed Eleojo Musa +3

    Sharh maqola20207 iqtibos
    ABI

  4. The radioprotective effects of alpha-lipoic acid on radiotherapy-induced toxicities: A systematic review

    Sahar Sheikholeslami, Shaghayegh Khodaverdian, Masoumeh Dorri-Giv +6

    Sharh maqola20217 iqtibos
    ABI

  5. Modulation of apoptosis by melatonin for improving cancer treatment efficiency: An updated review

    Keywan Mortezaee, Masoud Najafi, Bagher Farhood +4

    Sharh maqola20196 iqtibos
    ABI

  6. The role of melatonin on doxorubicin-induced cardiotoxicity: A systematic review

    Masoud Najafi, Mohammad Reza Hooshangi Shayesteh, Keywan Mortezaee +2

    Sharh maqola20196 iqtibos
    ABI

  7. The role of melatonin on radiation-induced pneumonitis and lung fibrosis: A systematic review

    Sahar Sheikholeslami, Tayebeh Aryafar, Razzagh Abedi‐Firouzjah +6

    Sharh maqola20216 iqtibos
    ABI

  8. Silybin, a Major Bioactive Component of Milk Thistle (Silybum marianum L. Gaernt.)—Chemistry, Bioavailability, and Metabolism

    Michał Bijak

    Sharh maqola20175 iqtibos
    ABI

  9. Curcumin as an anti‐inflammatory agent: Implications to radiotherapy and chemotherapy

    Bagher Farhood, Keywan Mortezaee, Nasser Hashemi Goradel +5

    Sharh maqola20185 iqtibos
    ABI

  10. Silymarin as Supportive Treatment in Liver Diseases: A Narrative Review

    Anton Gillessen, Hartmut Schmidt

    Sharh maqola20205 iqtibos
    ABI

  11. Damage-associated molecular patterns in tumor radiotherapy

    Milad Ashrafizadeh, Bagher Farhood, Ahmed Eleojo Musa +2

    Sharh maqola20205 iqtibos
    ABI

  12. A systematic review of the therapeutic effects of resveratrol in combination with 5-fluorouracil during colorectal cancer treatment: with a special focus on the oxidant, apoptotic, and anti-inflammatory activities

    Hossein Moutabian, Mehrsa Majdaeen, Ruhollah Ghahramani‐Asl +6

    Sharh maqola20225 iqtibos
    ABI

  13. Cancer treatment and survivorship statistics, 2019

    Kimberly D. Miller, Letícia Nogueira, Angela B. Mariotto +6

    MaqolaCancer survivorship and careCA A Cancer Journal for Clinicians20194 iqtibos
    ABI

  14. Nano-silymarin provides protection against γ-radiation-induced oxidative stress in cultured human embryonic kidney cells

    Manish Adhikari, Rajesh Arora

    Maqola20154 iqtibos
    ABI

  15. Silymarin Inhibits Cervical Cancer Cell Through an Increase of Phosphatase and Tensin Homolog

    Hann‐Chin Yu, Li‐Jen Chen, Kai‐Chun Cheng +3

    Maqola20114 iqtibos
    ABI

  16. Pharmacokinetic study of iodine-labeled silibinins in rat

    Nina Škottová, Zdeněk Švagera, Rostislav Večeřa +3

    Maqola20014 iqtibos
    ABI

  17. Flavonoid Antioxidant Silymarin and Skin Cancer

    Rana P. Singh, Rajesh Agarwal

    Sharh maqola20024 iqtibos
    ABI

  18. Effects of silymarin flavonolignans and synthetic silybin derivatives on estrogen and aryl hydrocarbon receptor activation

    Martina Plíšková, Jan Vondráček, Vladimı́r Křen +6

    Maqola20054 iqtibos
    ABI

  19. Advances in the Use of Milk Thistle ( <i>Silybum marianum</i> )

    Janice Post‐White, Elena J. Ladas, Kara M. Kelly

    Sharh maqola20074 iqtibos
    ABI

  20. Design, Synthesis, and Examination of Neuron Protective Properties of Alkenylated and Amidated Dehydro-Silybin Derivatives

    Lei Yang, Ke Huang, Hai Bo Li +11

    Maqola20094 iqtibos
    ABI

  21. Silymarin in the Prevention and Treatment of Liver Diseases and Primary Liver Cancer

    János Fehér, Gabriella Lengyel

    Sharh maqola20114 iqtibos
    ABI

  22. Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liver

    Peter Ferenci, B Dragosics, H. Dittrich +6

    Maqola19894 iqtibos
    ABI

  23. Improved dissolution and bioavailability of silymarin delivered by a solid dispersion prepared using supercritical fluids

    Gang Yang, Yaping Zhao, Nianping Feng +3

    Maqola20144 iqtibos
    ABI

  24. Chemoenzymatic Preparation of Oligoglycosides of Silybin, the Flavonolignan from Silybum marianum

    Vilı́m Šimánek, Jiří Kubisch, Petr Sedmera +4

    Maqola20014 iqtibos
    ABI

  25. Antioxidant properties of silybin glycosides

    Pavel Kosina, Vladim�r K en, Rolf Gebhardt +3

    Maqola20024 iqtibos
    ABI